Vitamin D questions on Step 1 love to look “simple” (sunlight → strong bones) and then test you on the one enzyme, organ, or regulator that breaks the chain. If you can trace vitamin D from skin → liver → kidney → intestine/bone and map what PTH, phosphate, FGF23, and kidney disease do to that pathway, you’ll crush most calcium/bone metabolism stems.
Big Picture: What Vitamin D Does (and Why Step 1 Cares)
Vitamin D (calcitriol, ) is a steroid hormone that primarily:
- Increases intestinal absorption of calcium and phosphate
- Promotes bone mineralization when Ca/Phos supply is adequate
- Can increase bone resorption (via RANKL) in certain contexts to maintain serum calcium
On exams, vitamin D is often tested in the context of:
- Rickets/osteomalacia
- CKD (renal osteodystrophy)
- Hypo/hyperparathyroidism
- Malabsorption
- Granulomatous disease → hypercalcemia
Vitamin D Metabolism: The High-Yield Pathway
Stepwise conversion (know the organs + enzymes)
| Step | Substrate → Product | Where | Enzyme | Regulation (HY) |
|---|---|---|---|---|
| 1 | 7-dehydrocholesterol → Cholecalciferol (D3) | Skin | UVB | ↓ with sunscreen, darker skin, low sun exposure |
| 2 | D3 → 25-hydroxyvitamin D (calcidiol) | Liver | 25-hydroxylase | Mostly substrate-driven; best measure of body stores |
| 3 | 25(OH)D → 1,25-dihydroxyvitamin D (calcitriol) | Kidney (proximal tubule) | 1α-hydroxylase | ↑ by PTH, ↓ by phosphate, ↓ by FGF23 |
Two lab values that Step 1 loves to trick you with
- 25(OH)D (calcidiol) = storage form and best test for vitamin D deficiency
- 1,25(OH)D (calcitriol) = active form and can be normal or even high in deficiency (because PTH upregulates 1α-hydroxylase)
Regulation: Who Turns Calcitriol Up or Down?
Parathyroid hormone (PTH): the “kidney activator”
Low calcium → ↑ PTH → kidney:
- ↑ 1α-hydroxylase → ↑ calcitriol
- ↑ Ca reabsorption (DCT)
- ↓ phosphate reabsorption (PCT) → phosphaturia
- ↑ bone resorption (via osteoblast RANKL → osteoclast activation)
Net: raises serum calcium; lowers serum phosphate.
Phosphate & FGF23: the “calcitriol brakes”
- High phosphate stimulates FGF23 (made by osteocytes)
- FGF23:
- ↓ 1α-hydroxylase → ↓ calcitriol
- ↓ phosphate reabsorption in PCT (phosphaturia)
Classic teaching: FGF23 is the body’s “anti-phosphate” hormone and reduces active vitamin D.
Mechanism of Action: How Vitamin D Works at Target Tissues
Intestine (highest yield)
Calcitriol increases:
- Calcium absorption (via ↑ TRPV6 channels, ↑ calbindin)
- Phosphate absorption
Bone
Vitamin D:
- Supports mineralization by providing Ca/Phos availability
- In conjunction with PTH, can promote resorption (upregulates RANKL via osteoblasts)
Kidney
Calcitriol modestly:
- Increases Ca/Phos reabsorption, but its major “exam effect” is through the gut.
Deficiency: Pathophysiology You’ll Actually See in Questions
Common causes
- Low sunlight exposure (institutionalized, high latitude)
- Darker skin (melanin blocks UVB)
- Malabsorption (celiac, Crohn, pancreatic insufficiency, bariatric surgery)
- Liver disease (↓ 25-hydroxylation)
- CKD (↓ 1α-hydroxylation → low calcitriol)
- Medications: enzyme inducers like phenytoin, phenobarbital (increase vitamin D catabolism)
What deficiency does to labs (pattern recognition)
Low vitamin D → ↓ intestinal Ca/Phos absorption → low calcium (or low-normal) → secondary hyperparathyroidism → phosphate wasting.
Typical deficiency labs:
- ↓ 25(OH)D
- ↓ Ca (may be low-normal early)
- ↓ phosphate (because PTH wastes phosphate)
- ↑ PTH
- ↑ alkaline phosphatase (high bone turnover/osteoblast activity)
HY nuance: In early deficiency, calcium may be normal due to compensatory PTH—so the giveaway becomes low phosphate + high PTH + high ALP + low 25(OH)D.
Clinical Presentations (Step-Style)
Rickets (kids)
Think: failure of mineralization at growth plates.
- Bone deformities: bowed legs (genu varum), knock-knees
- Rachitic rosary (enlarged costochondral junctions)
- Craniotabes, delayed closure of fontanelle
- Delayed growth, delayed tooth eruption
Osteomalacia (adults)
Think: poorly mineralized osteoid.
- Diffuse bone pain, tenderness
- Proximal muscle weakness
- ↑ fracture risk (especially insufficiency fractures)
Diagnosis: What to Order and How to Interpret It
Best initial test for vitamin D status
- Serum 25(OH)D
Helpful add-ons (often tested together)
- Calcium, phosphate, PTH, alkaline phosphatase
- Consider celiac testing or malabsorption workup if persistent
Imaging clues (less common but very Step 1)
- Rickets: metaphyseal cupping/fraying on X-ray
- Osteomalacia: Looser zones/pseudofractures
Treatment (and Exam-Relevant “Which Form Do I Give?”)
Nutritional deficiency (most common)
- Vitamin D3 (cholecalciferol) supplementation
- Ensure adequate calcium intake
Malabsorption or severe deficiency
- Higher-dose vitamin D regimens; sometimes calcidiol/calcitriol depending on context
- Treat underlying cause (celiac, pancreatic insufficiency, etc.)
CKD: key twist
- Kidney can’t do 1α-hydroxylation → low calcitriol even if 25(OH)D is okay
- Treat with active vitamin D:
- Calcitriol (1,25(OH)D) or analogs (e.g., paricalcitol)
- Also manage hyperphosphatemia (dietary phosphate restriction, phosphate binders)
Hypervitaminosis D and Hypercalcemia: The “Overdose” Pattern
Excess vitamin D (supplements) → hypercalcemia + hyperphosphatemia because intestinal absorption of both rises.
Findings:
- Nausea, constipation, polyuria, confusion
- Nephrolithiasis
- Shortened QT (hypercalcemia)
Labs:
- ↑ Ca, ↑ phosphate, ↓ PTH
Management is cause-dependent (stop supplements; IV fluids; consider bisphosphonates/calcitonin if significant hypercalcemia).
High-Yield Associations & Classic Vignettes
1) Chronic kidney disease → low calcitriol → secondary hyperparathyroidism
Mechanism: ↓ 1α-hydroxylase + phosphate retention → ↓ Ca → ↑ PTH
Labs: ↓ Ca, ↑ phosphate, ↑ PTH, ↑ ALP
Buzzwords: “renal osteodystrophy,” bone pain, pruritus, vascular calcifications.
2) Granulomatous disease (sarcoid, TB) → hypercalcemia
Macrophages express 1α-hydroxylase outside kidney → ↑ calcitriol independent of PTH.
Labs: ↑ Ca, ↓ PTH, ↑ 1,25(OH)D
Clue: hypercalcemia in sarcoidosis with hilar adenopathy.
3) Anticonvulsants (phenytoin/phenobarbital) → vitamin D deficiency
Induce CYP450 → ↑ vitamin D breakdown → osteomalacia/rickets risk.
4) Liver disease affects 25-hydroxylation
Leads to low 25(OH)D and downstream effects.
Rapid-Fire Step 1 “If You See X, Think Y”
- Best indicator of vitamin D stores → 25(OH)D
- PTH increases calcitriol → stimulates 1α-hydroxylase
- FGF23 decreases calcitriol and increases phosphate wasting
- CKD → can’t activate vitamin D → treat with calcitriol
- Sarcoidosis/TB → ectopic 1α-hydroxylase → hypercalcemia with low PTH
- Vitamin D deficiency → ↑ PTH, ↑ ALP, often ↓ phosphate
First Aid Cross-References (Where This Lives in FA)
Use these as your quick “flip-to” anchors (edition-dependent headings may shift slightly):
- Endocrine → Calcium homeostasis: PTH vs vitamin D actions (bone, kidney, gut)
- Renal → Chronic kidney disease: secondary hyperparathyroidism / renal osteodystrophy
- Musculoskeletal → Bone disorders: rickets, osteomalacia, osteoporosis differentiation
- Endocrine pharmacology: vitamin D preparations (cholecalciferol, ergocalciferol, calcitriol)
(Exact page numbers vary by edition; search within FA for “1α-hydroxylase,” “FGF23,” “rickets,” and “renal osteodystrophy.”)
Mini Table: Differentiate Bone Conditions Fast
| Condition | Primary problem | Calcium | Phosphate | PTH | ALP |
|---|---|---|---|---|---|
| Vitamin D deficiency (rickets/osteomalacia) | Low mineralization (low Vit D) | ↓ / low-normal | ↓ | ↑ | ↑ |
| CKD bone disease | ↓ calcitriol + phosphate retention | ↓ | ↑ | ↑ | ↑ |
| Primary hyperparathyroidism | Excess PTH | ↑ | ↓ | ↑ | ↑ |
| Vitamin D toxicity | Excess absorption | ↑ | ↑ | ↓ | variable |